ONKOATLAS, OOO, Novosibirsk Oblast

Accounting reports

Previously

Name	ONKODIAGNOSTIKA ATLAS, OOO
INN	5408287687
KPP	770601001
OGRN	1115476059401
OKPO	91709359
Address	119049, G.Moskva, pr-kt. Leninskiy, d. 4, pomesch. 2/2

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities ONKOATLAS, OOO according to EGRUL
72.19	Core activity	Research and experimental development on natural sciences and engineering Other
21.20.2	Additional activity	Production of materials used in medical applications
46.46	Additional activity	Wholesale of pharmaceutical goods
All types of activities
47.74	Additional activity	Retailing products used for medical purposes, orthopedic goods in specialized stores
74.20	Additional activity	Interior Design and Interior Design
74.30	Additional activity	Translation and interpretation activities
82.92	Additional activity	Activities of packing goods
86	Additional activity	Health service
86.90.9	Additional activity	Other independent activities in health care

Registration information

Registration date	17.05.2011
Registering department	Mezhrayonnaya inspektsiya FNS Rossii 16 po Novosibirskoy oblasti

Description

ONKOATLAS, OOO (Novosibirsk Oblast; INN 5408287687) was registered on 17 May 2011. The company's authorized capital as of July 1, 2012 was 11579 rub.

Type of ownership of ONKOATLAS, OOO - Limited liability companies.

Form of ownership of ONKOATLAS, OOO - Private property.

Principal activities of ONKOATLAS, OOO: research and experimental development on natural sciences and engineering other (72.19), production of materials used in medical applications (21.20.2), wholesale of pharmaceutical goods (46.46).

Industry

Economic indicators

2022

Net loss (RAS) of ONKOATLAS, OOO dropped over 2022 by 33.82% to 6.30 million RUB from 9.51 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period 1.59 times to 116.32 million RUB from 73.28 million RUB over 2021; cost of goods sold grew 1.74 times to 59.87 million RUB from 34.40 million RUB; sales loss decreased by 18.58% to 18.90 million RUB from 23.21 million RUB.

2021

Net loss (RAS) of ONKODIAGNOSTIKA ATLAS, OOO increased 3.80 times to 9.51 million RUB from 2.50 million RUB over 2020, the company informed.

Revenue increased in the accounting period 2.06 times to 73.28 million RUB from 35.57 million RUB over 2020.

2020

Net loss (RAS) of ONKODIAGNOSTIKA ATLAS, OOO dropped over 2020 3.78 times to 2.50 million RUB from 9.45 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period 1.50 times to 35.57 million RUB from 23.70 million RUB over 2019.

2018

Net loss (RAS) of ONKODIAGNOSTIKA ATLAS, OOO increased 1.89 times to 5.49 million RUB from 2.90 million RUB over 2017, the company informed.

Revenue increased in the accounting period 1.78 times to 11.04 million RUB from 6.21 million RUB over 2017; cost of goods sold grew 1.85 times to 16.82 million RUB from 9.10 million RUB; sales loss grew 2.00 times to 5.78 million RUB from 2.89 million RUB.

2017

Net loss (RA) of ONKODIAGNOSTIKA ATLAS, OOO made up 2.90 million RUB over 2017 compared to net profit of 259.00 thousand RUB over 2016, the company informed.

Revenue decreased in the accounting period by 7.95% to 6.21 million RUB from 6.75 million RUB in 2016; cost of goods sold grew by 41.15% to 9.10 million RUB from 6.45 million RUB; sales loss made up 2.89 million RUB compared to sales profit of 304.00 thousand RUB.

2016

Net profit (RAS) of ONKODIAGNOSTIKA ATLAS, OOO made up 259.00 thousand RUB over 2016 compared to net loss of 1.45 million RUB over 2015, the company informed.

Revenue increased in the accounting period 9.64 times to 6.75 million RUB from 700.00 thousand RUB over 2015; cost of goods sold grew 3.06 times to 6.45 million RUB from 2.11 million RUB; sales profit made up 304.00 thousand RUB compared to sales loss of 1.41 million RUB.

2014

Net profit (RAS) of TSSB Genomika, OOO made up 2.10 million RUB over 2014 compared to net loss of 18.00 thousand RUB over 2013, the company informed.

2013

Net loss (RA) of TSSB Genomika, OOO made up 18.00 thousand RUB over 2013 compared to net profit of 228.00 thousand RUB over 2012, the company informed.

Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 270.00 thousand RUB in 2012; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 40.00 thousand RUB; sales profit made up 0 RUB compared to 230.00 thousand RUB.

2012

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 193 999

Reports

17 430 848

Rrocessed requests

Extract from EGRUL:

Today, 9:23 PM

Accounting reports:

Today, 9:26 PM